Honeywell (HON) 2025 — Grade F: Goodwill 200% of Equity, Three-Way Breakup

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2026, FY ended December 31, 2025) + Yahoo Finance

Auditor: Deloitte & Touche LLP — Unqualified opinion (1 critical audit matter: long-term contract revenue recognition)

One-line verdict: Honeywell is a conglomerate in the middle of breaking itself apart, and the balance sheet shows it. Goodwill plus intangibles at $27.8B represent 200% of equity — meaning every dollar of shareholder equity is backed by two dollars of acquisition-era goodwill. Cash of $12.9B covers only 36% of $35.6B in total debt. Debt/EBITDA is 4.3x, the highest among the companies we screen. But the income statement tells a different story: $37.4B in revenue (up 8%), $6.4B in operating cash flow, CFFO/NI of 1.36, and an M-Score of -2.59 that is comfortably clean. The auditor's critical audit matter — long-term contract cost estimation — reflects the inherent complexity of aerospace and defense contracts, not an accounting deficiency. The real risk in this 10-K is the planned separation into two public companies (Honeywell and Honeywell Aerospace), the Solstice Advanced Materials spin-off already completed, and an additional divestiture of two business units being evaluated. Honeywell is simultaneously leveraged, restructuring, and breaking apart — a combination that demands close monitoring.

A Company Breaking Itself Apart

The 10-K describes three major corporate actions underway:

This means the 10-K financials represent a company that will not exist in its current form within 18 months. The four reportable segments — Aerospace Technologies ($17.5B revenue), Industrial Automation ($9.4B), Building Automation ($7.4B), and Energy and Sustainability Solutions (UOP) — will be split across two separate public companies.

Financial Performance: Growth Amid Restructuring

From the consolidated statement of operations:

Per the MD&A, the 8% revenue growth was driven by: "increased pricing and price adjustments to offset inflation" (4%), "incremental sales from recent acquisitions" (4%), and "higher sales volumes" (3%), partially offset by "lower sales from the divestiture of the PPE business" (-2%).

Gross margin declined 160 basis points from 38.5% to 36.9%. The MD&A attributes this to "incremental costs from recent acquisitions of approximately $0.9 billion or 4%, higher direct and indirect material costs and higher labor costs of approximately $0.7 billion or 3%." The margin contraction despite 4% pricing reflects cost inflation outpacing price increases — a pattern that warrants monitoring.

Net income declined because income from continuing operations fell $527M (from $4,995M to $4,468M) due to the margin compression and a $724M goodwill impairment charge and $270M impairment of assets held for sale. Income from discontinued operations dropped from $745M to $304M following the Solstice spin-off.

R&D investment surged: Company-funded R&D rose from $1,454M to $1,812M (+24.6%), driven by "increased investment in new product development in our Aerospace Technologies business."

Cash Flow: Strong Conversion, Improving Trend

CFFO/NI improved from 0.94 to 1.36 over three years — cash conversion is accelerating. The FY2023 ratio below 1.0 was a watch item; its normalization above 1.0 is positive. Free cash flow of $5.4B grew 18% over two years.

The filing states the company "deployed $10.0 billion to capital expenditures, dividends, share repurchases, and mergers and acquisitions." The company has maintained its "commitment to reduce share count by at least 1% per year and increased our dividend for the sixteenth time in the last fifteen years."

Balance Sheet: The Leverage Concern

From the consolidated balance sheet:

*Includes commercial paper, current maturities, and long-term debt.

Equity declined from $18.6B to $13.9B — driven primarily by $1.6B in comprehensive loss (foreign exchange and pension adjustments), share buybacks, dividends, and the Solstice spin-off impact. Accumulated other comprehensive loss of $5.1B reflects pension obligations and foreign currency translation.

Goodwill at $21.1B is 152% of equity. Add intangibles ($6.7B) and the ratio rises to 200%. This is the legacy of decades of acquisitions — particularly the 1999 AlliedSignal-Honeywell merger and subsequent bolt-ons. The 10-K includes a $724M goodwill impairment charge, demonstrating this is not a hypothetical risk.

Debt/EBITDA of 4.3x exceeds the 4.0x threshold our framework considers financially stressed. However, interest coverage of 4.9x (operating income / interest expense of $1,344M) shows the company can service its debt. The rising interest expense — from $749M (FY2023) to $1,048M (FY2024) to $1,344M (FY2025) — reflects both higher rates and higher debt levels.

The 18-Point Screening

Revenue Quality

Revenue quality is clean. DSO improved and AR growth trails revenue growth — the opposite of typical manipulation signals.

Expense Quality

The gross margin decline of 160 basis points is within the screening framework's tolerance (it does not trigger a flag unless the decline exceeds 300 basis points or continues for multiple years). But the direction is negative and bears watching.

Cash Flow Quality

Balance Sheet

D1 and D2 are the core concerns. The combination of goodwill at 200% of equity and leverage at 4.3x means that a modest goodwill impairment combined with debt refinancing costs could erode equity significantly. The FY2025 $724M goodwill impairment demonstrates this risk is real.

Acquisition Risk

Manipulation Score

All M-Score components are benign: DSRI 0.975, GMI 1.042, AQI 0.921, SGI 1.078, DEPI 0.890, SGAI 0.965, TATA -0.023, LVGI 1.105. The DEPI of 0.890 (below 1.0) indicates accelerating depreciation — consistent with increased CapEx and new asset deployment.

Key Risks from the 10-K

1. Separation Execution Risk

The filing describes the planned separation into Honeywell and Honeywell Aerospace as two independent public companies by Q3 2026. The risk factors warn about "the proposed separation of Honeywell from Honeywell Aerospace and the planned sale of the Productivity Solutions and Services and Warehouse and Workflow Solutions businesses." Any separation involves dis-synergies, stranded costs, and management distraction. The filing explicitly states that "no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this Form 10-K can or will be achieved."

2. Tariff and Trade Policy Exposure

The risk factors state: "The recent changes in U.S. trade policy involving the application or increase of tariffs and the subsequent retaliatory measures against the U.S. have created a dynamic environment that may have a material adverse impact on our business." More than half of Honeywell's sales come from non-U.S. jurisdictions. The filing warns of "the adoption and expansion of, and other changes to, trade restrictions and tariffs, quotas, embargoes, and other related actions."

3. Long-term Contract Estimation — The Auditor's Critical Audit Matter

Deloitte identified revenue recognition on long-term contracts as the critical audit matter. The filing states these contracts require "management's judgment in estimating total contract costs." Contract costs "can be incurred over several years" and are "largely determined based on negotiated or estimated purchase contract terms and consider factors such as historical performance trends, inflationary trends, technical and schedule risk." For aerospace and defense contracts, cost overruns can turn profitable contracts into losses.

4. Asbestos and Environmental Liabilities

The balance sheet shows asbestos-related liabilities of $1.3B. This is a legacy obligation that persists from Honeywell's industrial history. Environmental remediation obligations add further long-tail liability exposure.

5. Aerospace Cyclicality and Defense Budget Dependence

Aerospace Technologies ($17.5B revenue) is the largest segment and the one being separated. The filing warns that "operating results may be adversely affected by downturns in the global demand for air travel" and that defense results "may be affected by the mix of U.S. and foreign government appropriations for defense and space programs." Post-separation, the Aerospace entity will have concentrated cyclical exposure.

6. Gross Margin Compression

Gross margin declined 160 basis points despite 4% pricing. The MD&A attributes this to acquisition cost absorption and material/labor inflation. If pricing power cannot keep pace with cost inflation, the margin deterioration could accelerate.

Summary

Grade: F. The leverage and goodwill concentration are real risks, amplified by the ongoing corporate breakup. Monitor the separation execution and debt reduction plan.

Honeywell's operating metrics are solid: $37.4B revenue growing 8%, CFFO/NI of 1.36, FCF of $5.4B, and an M-Score of -2.59 that is comfortably clean. The revenue quality checks all pass — DSO is improving and AR trails revenue growth.

The F grade is driven by the balance sheet: goodwill at 200% of equity, cash covering only 36% of debt, and Debt/EBITDA at 4.3x. The $724M goodwill impairment in FY2025 demonstrates the write-down risk is real, not theoretical. The planned separation into two companies, combined with additional divestitures, means the capital structure will be rebuilt — for better or worse.

The key question for investors: How will $35.6B in debt and $27.8B in goodwill be allocated between Honeywell and Honeywell Aerospace? The answer will determine whether the post-separation entities have manageable or dangerous leverage.

**Disclaimer**: This report is based on Honeywell's FY2025 10-K filed with SEC EDGAR. This is NOT investment advice.

Data: SEC EDGAR 10-K + Yahoo Finance

Auditor: Deloitte & Touche LLP (Unqualified opinion, 1 critical audit matter — long-term contract revenue recognition)

Fiscal year ended: December 31, 2025